Moustafine R I, Kabanova T V, Kemenova V A, Van den Mooter G
Department of Pharmaceutical Chemistry, State Medical University of Kazan, Kazan, Russia.
J Control Release. 2005 Mar 2;103(1):191-8. doi: 10.1016/j.jconrel.2004.11.031. Epub 2005 Jan 13.
With a view to the application in oral controlled drug delivery systems, the formation of interpolyelectrolyte complexes (IPEC) between Eudragit E100 (EE) and Eudragit L100 (EL) was investigated, using turbidimetry, solution viscosity measurements and elementary analysis. The structure of the synthesized IPEC was investigated by using FT-IR spectroscopy. The binding ratio of a unit molecule of EL with EE was found to be approximately 1:1 in pH 6.0. Based on the results of elementary analysis, and FT-IR, the binding ratio of each component in the solid complexes was very close to that observed in turbidity and viscosity measurements and indicate that the synthesized products can be considered as IPEC. Due to the structure of the IPEC, two maxima were observed in the swelling behaviour as a function of pH. The release of the model drug ibuprofen was significantly retarded from tablets made up of the IPEC.
为了将其应用于口服控释给药系统,采用比浊法、溶液粘度测量和元素分析等方法,研究了Eudragit E100(EE)和Eudragit L100(EL)之间聚电解质复合物(IPEC)的形成。利用傅里叶变换红外光谱(FT-IR)对合成的IPEC结构进行了研究。发现在pH 6.0时,EL与EE的单位分子结合比约为1:1。基于元素分析和FT-IR的结果,固体复合物中各组分的结合比与比浊和粘度测量中观察到的结果非常接近,表明合成产物可被视为IPEC。由于IPEC的结构,在溶胀行为随pH值变化时观察到两个最大值。由IPEC制成的片剂中模型药物布洛芬的释放明显延迟。